A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

New Thermal Imaging Cart with Onboard Power

Supports a Healthier, Safer Return to Work Reports Ergotron

Ergotron, a global movement company that builds environments that help people thrive, announced the launch of its Thermal Imaging Cart with Onboard Power designed to quickly detect a temperature in spaces where groups of people gather.

As employers slowly start to bring their teams back to work, businesses gradually begin to reopen, and educators weigh their options for the upcoming school year, safeguarding public health is a top priority. Thermal imaging technology brings body temperature measurement wherever it’s needed to support efforts to maintain healthy communities.

Ergotron’s Thermal Imaging Cart provides total flexibility. The cart’s open architecture allows for customers to mount their thermal imaging camera of choice* facing forward or backward depending on the application or to accommodate privacy considerations. The easy-to-clean mobile cart is compact and fits in small spaces so it can travel to wherever it’s needed. Optional accessories like a sani-wipes holder make disinfection simple and the onboard LiFe battery technology provides a safe and reliable charge.

“We developed the Thermal Imaging Cart based on a need we recognized in our customers and in the marketplace,” said Megan Nightingale, general manager, industrial, education and new markets at Ergotron. “As we navigate this new world we’re in, we’ve seen a huge demand for thermal imaging solutions. Our cart fits a variety of thermal imaging cameras and we’re excited to introduce this solution to support employers, businesses and educators as they work to keep their populations healthy.”

In addition to the Thermal Imaging Cart with Onboard Power, a Thermal Imaging Cart with Hot Swap Power is also available to order. Hot swap power, with Ergotron’s innovative LifeKinnex™ Technology, allows for uninterrupted workflows. These carts can be ordered from resellers globally. For more information, visit ergotron.com or call 888-743-1999.

* Camera, monitor and other equipment sold separately. Ergotron does not manufacture, sell or endorse any thermal camera. Mobotix® is a registered trademark of Mobotix AG Corporation.

SourceErgotron
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy